This information is intended for U.S. healthcare professionals and/or healthcare professionals involved in healthcare reimbursement. Bristol Myers Squibb Access Support^®

Payer Details

Change Medication

PRINT

[Payer Name – Plan Type]
Payer Links
Payer Contact Information	Phone Number: Not Specified Fax Number: Not Specified
Utilization Criteria
Prior Authorization/ Pre-Certification	Not specified
Prior Authorization/ Pre-Certification Duration	Not specified
Quantity Limits	Not specified
Documentation Requirements	Not specified
Other Information
Diagnostic Information	Not specified

Coverage may vary based upon a patient's specific plan benefits. You may also refer to Bristol Myers Squibb Access Support at 1-800-861-0048 for a benefits investigation for your specific patient.

Last Review Date: Not Specified

Viewing Details For

Drug: [Drug Name]

Payer: [Payer Name – Plan Type]

Edit Payer Details >

For coding and billing information, click here.

IMPORTANT INFORMATION BELOW

While Bristol-Myers Squibb Company strives to make the information on this website as timely and accurate as possible, the Company makes no claims, promises, or guarantees about the accuracy, completeness, or adequacy of the contents of this site, and expressly disclaims liability for errors and omissions in the contents of this site. Bristol Myers Squibb does not guarantee coverage of insured benefits; all benefits are subject to the insured's plan requirements. Please consult the health plan directly for comprehensive policy information. Upon rendering his or her own independent clinical judgment, it is up to the Healthcare Professional to determine patient specific coverage.

This information may not be consistent with the current product prescribing information. Bristol Myers Squibb neither endorses, nor recommends, uses that are not consistent with the FDA-approved prescribing information.

Reference in this site to any specific payer plan does not constitute endorsement, recommendation, or favoring by Bristol Myers Squibb and inclusion in a medical policy does not imply comparable or superior efficacy/safety of drug products.